Urine L-FABP and the urine AN-3199 biological activity albumin excretion rate are plotted in Figure 1. The levels of serum L-FABP (76932-56-4 web Pearson correlation: 20.310, P,.0.001) and urine L-FABP (Pearson correlation: 20.276, P = 0.001), and the urine albumin excretion rate (Pearson correlation: 20.333, P,0.001), were significantly correlated with the eGFR. The correlations between eGFR and serum/urine L-FABP were not significant. The results of correlation analysis for the correlations between baseline eGFR and the baseline levels of serum NGAL, serum LFABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate are summarized in 1531364 Table 4 and 5. The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR by multiple regression analysis (P,0.05). The correlations between baseline eGFR and serum NGAL, urine NGAL and urine L-FABP levels were not significant (Table 4). Due to the distribution of baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP and the urine albumin excretion rate were not normal by Shapiro-Wilk W test (P.0.05), Spearman’s rank correlation coefficient was calculated. The results showed that baseline urine albumin excretion rate, urine NGAL, and serum/urine L-FABP levels were significantly correlated with baseline eGFR (P,0.05) (Table 5).DiscussionDiabetic nephropathy is currently the leading cause of CKD. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes [25]. It is well known that severe tubulointerstitial damage is associated with a faster decline in eGFR in CKD patients [26]. In this study, we used two renal tubular injury biomarkers, NGAL and L-FABP, in addition to albuminuria, to predict the GFR decline rate in type 2 diabetic patients. Our results showed that the serum L-FABP level was significantly associated with eGFR, using regression analysis in the cross-sectional study. However, only thePredicting GFR Decline in Type 2 DM PatientsFigure 2. Pearson correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate. doi:10.1371/journal.pone.0054863.gurine albumin excretion rate was significantly associated with eGFR and the eGFR decline rate in type 2 diabetic patients. Tubulointerstitial and glomerular injuries have important roles in the pathogenesis of diabetic nephropathy [2]. Several recent studies demonstrated that urinary tubular damage markers, such as KIM-1, NGAL and L-FABP, may have the potential to beclinical markers for identifying the development or progression of diabetic nephropathy [27?0]. It was also reported that urine NGAL was significantly elevated in type 1 diabetic patients with or without albuminuria, and that urine NGAL increased significantly with increasing albuminuria [27]. However, some 1317923 studies have shown conflicting results. A study with type 2 diabetic patientsPredicting GFR Decline in Type 2 DM PatientsTable 6. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Table 7. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Rate of eGFR decline Urine albumin Serum NGAL Serum L-FABP Urine NGAL Urine L-FABPStandardized coefficients.Urine L-FABP and the urine albumin excretion rate are plotted in Figure 1. The levels of serum L-FABP (Pearson correlation: 20.310, P,.0.001) and urine L-FABP (Pearson correlation: 20.276, P = 0.001), and the urine albumin excretion rate (Pearson correlation: 20.333, P,0.001), were significantly correlated with the eGFR. The correlations between eGFR and serum/urine L-FABP were not significant. The results of correlation analysis for the correlations between baseline eGFR and the baseline levels of serum NGAL, serum LFABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate are summarized in 1531364 Table 4 and 5. The baseline urine albumin excretion rate and serum L-FABP level were significantly correlated with baseline eGFR by multiple regression analysis (P,0.05). The correlations between baseline eGFR and serum NGAL, urine NGAL and urine L-FABP levels were not significant (Table 4). Due to the distribution of baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP and the urine albumin excretion rate were not normal by Shapiro-Wilk W test (P.0.05), Spearman’s rank correlation coefficient was calculated. The results showed that baseline urine albumin excretion rate, urine NGAL, and serum/urine L-FABP levels were significantly correlated with baseline eGFR (P,0.05) (Table 5).DiscussionDiabetic nephropathy is currently the leading cause of CKD. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes [25]. It is well known that severe tubulointerstitial damage is associated with a faster decline in eGFR in CKD patients [26]. In this study, we used two renal tubular injury biomarkers, NGAL and L-FABP, in addition to albuminuria, to predict the GFR decline rate in type 2 diabetic patients. Our results showed that the serum L-FABP level was significantly associated with eGFR, using regression analysis in the cross-sectional study. However, only thePredicting GFR Decline in Type 2 DM PatientsFigure 2. Pearson correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate. doi:10.1371/journal.pone.0054863.gurine albumin excretion rate was significantly associated with eGFR and the eGFR decline rate in type 2 diabetic patients. Tubulointerstitial and glomerular injuries have important roles in the pathogenesis of diabetic nephropathy [2]. Several recent studies demonstrated that urinary tubular damage markers, such as KIM-1, NGAL and L-FABP, may have the potential to beclinical markers for identifying the development or progression of diabetic nephropathy [27?0]. It was also reported that urine NGAL was significantly elevated in type 1 diabetic patients with or without albuminuria, and that urine NGAL increased significantly with increasing albuminuria [27]. However, some 1317923 studies have shown conflicting results. A study with type 2 diabetic patientsPredicting GFR Decline in Type 2 DM PatientsTable 6. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Table 7. Correlation between the rate of eGFR decline and the baseline levels of serum NGAL, serum L-FABP, urine NGAL, and urine L-FABP, and the urine albumin excretion rate.Rate of eGFR decline Urine albumin Serum NGAL Serum L-FABP Urine NGAL Urine L-FABPStandardized coefficients.
Related Posts
Carry a sizable array of cargoes, from nanoparticles, peptides, nucleic acids and also proteins into
Carry a sizable array of cargoes, from nanoparticles, peptides, nucleic acids and also proteins into cells and also the nucleus104. In vitro studies have shown that Tat is able to bind nuclear import receptors which mediate nuclear localisation5, 15, however, a structural basis for this interaction remains to be elucidated. There has also been someCharles […]
Stiffness and cell shape fluctuations Anna Elbieta Drod1; Tomasz Kolodziej1; Marta Targosz-Korecka1; Robert Jach2; Hubert
Stiffness and cell shape fluctuations Anna Elbieta Drod1; Tomasz Kolodziej1; Marta Targosz-Korecka1; Robert Jach2; Hubert Huras3; Ewa Stpie1 Faculty of Physics, Astronomy and Applied Laptop Science from the Jagiellonian University, Krak , Poland; 2Department of Gynecological Endocrinology, Faculty of Medicine of the Jagiellonian University Medical College, Krakow, Poland; 1Department of Obstetrics and Perinatology, Faculty of […]
Microarray gene expression experiments were then executed in triplicates for selected tissue samples and clinical endpoints were measured, although not for all possible drug-exposure conditions in all organs
Microarray gene expression experiments had been then 153259-65-5 manufacturer executed in triplicates for selected tissue samples and scientific endpoints have been calculated, despite the fact that not for all achievable drug-publicity problems in all organs. Based on the Natsoulis et al. [22] evaluation, we centered on a information-rich established of 2,218 Affymetrix microarrays from DrugMatrix […]